FDA Approves Replimune's Tudriqev for Advanced Melanoma After Two Previous Rejections Medical Daily 1d
Repl Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with SBS Law Business Wire (Press Release) 2d
Deadline Soon: Replimune Group, Inc. (Repl) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit Business Wire (Press Release) 2d
Deadline Approaching: Replimune Group, Inc. (Repl) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith Business Wire (Press Release) 2d
FDA approves first mRNA flu vaccine for people over 50 Skeptical Raptor 8h Moderna Vaccine Moderna mRNA All sources
FDA finally OKs twice-rejected melanoma drug Medpage Today 3d Replimune Cancer Treatment Pharma All sources
Takeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead Pharmaceutical Technology 4d Pharma All sources
